WilmerHale provides legal representation across a comprehensive range of practice areas critical to the success of its clients. With a staunch commitment to public service, the firm is a leader in pro bono representation. WilmerHale is 1,000 lawyers strong with 12 offices in the United States, Europe and Asia.
On September 22, 2017, Nabriva Therapeutics plc (NASDAQ:NBRV) closed on its underwritten public offering of 9,411,765 ordinary shares at a public offering price of $8.50 per share, totaling approximately $80 million.
United States
On September 22, 2017, Nabriva Therapeutics plc (NASDAQ:NBRV)
closed on its underwritten public offering of 9,411,765 ordinary
shares at a public offering price of $8.50 per share, totaling
approximately $80 million.
Nabriva's announcement regarding the pricing of this
offering can be found at www.nabriva.com.
Contributor
WilmerHale provides legal representation across a comprehensive range of practice areas critical to the success of its clients. With a staunch commitment to public service, the firm is a leader in pro bono representation. WilmerHale is 1,000 lawyers strong with 12 offices in the United States, Europe and Asia.
